All In Biotech

Drug Trial Radar · NCT07566429

A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)

A Phase 2, Open-label, Single Group, Fixed-dose Study to Evaluate the Safety and Efficacy of a Single Bilateral Intraputaminal Administration of AB-1005 (AAV2-GDNF Gene Therapy) in Japanese Participants With Moderate Stage Parkinson's Disease

Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

8

Planned (sponsor's estimate)

Start

Jan 25, 2027

Primary completion

Jun 15, 2029

Study completion Dec 15, 2032

Sponsor

Lead sponsor
BayerBayer (BAYRY)
Sponsor type
Industry
Collaborators
AskBio Inc
First posted
May 5, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 45 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this Phase 2, open-label, single group, one-time, fixed-dose study is to assess the safety and efficacy of bilateral intraputaminal infusion of AB-1005 (AAV2-GDNF gene therapy) in Japanese patients with moderate Parkinson's Disease (PD).

Conditions

  • Parkinson Disease

Interventions

  • AB-1005Drug

    Bilateral image-guided infusion of AAV2-GDNF into putamen, single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse events up to Month 18 after study interventionTime frame: Up to 18 months
  2. Change from Baseline to Month 18 in normalized Good ON time measured with PD Motor DiaryTime frame: Up to 18 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • National Hospital Organization Utano National Hospital - Neurology

    Kyoto, Japan

  • Nagoya Central Hospital - Neurosurgery

    Nagoya, Aichi-ken, Japan

  • Nagoya University Hospital - Neurology

    Nagoya, Aichi-ken, Japan

  • Yokohama City University Medical Center - Neurology

    Yokohama, Kanagawa, Japan

  • National Hospital Organization Osaka Toneyama Medical Center - Neurology

    Toyonaka, Osaka, Japan

  • Juntendo University Hospital - Neurology

    Bunkyo-ku, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.